A case of dupilumab combination therapy for exacerbation of atopic dermatitis in a patient with eosinophilic granulomatosis with polyangiitis treated with mepolizumab

被引：4
作者：
Iwadate, Yosuke [1 ]
Arinuma, Yoshiyuki [1 ]
Matsueda, Yu [1 ]
Tanaka, Tomoki [1 ]
Wada, Tatuhiko [1 ]
Tanaka, Sumiaki [1 ]
Oku, Kenji [1 ]
Yamaoka, Kunihiro [1 ]
机构：
[1] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Tokyo, Kanagawa, Japan
来源：
MODERN RHEUMATOLOGY CASE REPORTS | 2023年 / 8卷 / 01期
关键词：
Eosinophilic granulomatosis with polyangiitis (EGPA); atopic dermatitis (AD); mepolizumab; dupilumab;
D O I：
10.1093/mrcr/rxad059
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report a 60-year-old male with eosinophilic granulomatosis with polyangiitis (EGPA) complicated with atopic dermatitis (AD). The patient was initially treated with prednisolone, cyclosporine A, and mepolizumab (MEPO). Due to worsening skin symptoms after prednisolone tapering, dupilumab (DUP) was added as an adjunctive therapy for AD confirmed by skin biopsy. The combination therapy of MEPO and DUP resulted in rapid improvement of skin symptoms, suggesting it may be an effective therapeutic option for patients with EGPA and AD. This case report emphasises the importance of a multidisciplinary approach in treating complex diseases such as EGPA and AD.
引用
收藏
页码：159 / 162
页数：4
相关论文
共 13 条
  • [1] Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis
    Anai, Moriyasu
    Yoshida, Chieko
    Ozono, Kazutaka
    Furukawa, Hirotsugu
    Ishimaru, Yuko
    Sakata, Shinya
    Saruwatari, Koichi
    Muramoto, Kei
    Tomita, Yusuke
    Saeki, Sho
    Ichiyasu, Hidenori
    Sakagami, Takuro
    [J]. ALLERGOLOGY INTERNATIONAL, 2022, 71 (02) : 259 - 261
  • [2] 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Chung, Sharon A.
    Langford, Carol A.
    Maz, Mehrdad
    Abril, Andy
    Gorelik, Mark
    Guyatt, Gordon
    Archer, Amy M.
    Conn, Doyt L.
    Full, Kathy A.
    Grayson, Peter C.
    Ibarra, Maria F.
    Imundo, Lisa F.
    Kim, Susan
    Merkel, Peter A.
    Rhee, Rennie L.
    Seo, Philip
    Stone, John H.
    Sule, Sangeeta
    Sundel, Robert P.
    Vitobaldi, Omar, I
    Warner, Ann
    Byram, Kevin
    Dua, Anisha B.
    Husainat, Nedaa
    James, Karen E.
    Kalot, Mohamad A.
    Lin, Yih Chang
    Springer, Jason M.
    Turgunbaev, Marat
    Villa-Forte, Alexandra
    Turner, Amy S.
    Mustafa, Reem A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (08) : 1366 - 1383
  • [3] Effects of anti-IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real-life multicentre study (BIONIGE)
    Contoli, Marco
    Santus, Pierachille
    Menzella, Francesco
    Rocchi, Cindy
    Radovanovic, Dejan
    Baraldi, Federico
    Martelli, Chiara
    Casanova, Serena
    Barbetta, Carlo
    Micheletto, Claudio
    Scichilone, Nicola
    Beghe, Bianca
    Carpagnano, Elisiana
    Papi, Alberto
    [J]. CLINICAL AND TRANSLATIONAL ALLERGY, 2022, 12 (04)
  • [4] Two pediatric cases of ANCA-negative eosinophilic granulomatosis with polyangiitis successfully treated with dupilumab
    Galant-Swafford, Jessica
    Geng, Bob
    Leibel, Sydney
    Akuthota, Praveen
    Tucker, Suzanne
    Cernelc-Kohan, Matejka
    Sheets, Robert
    Nation, Javan
    Jefferson, Akilah A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (10) : 3643 - +
  • [5] Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
    Guttman-Yassky, Emma
    Bissonnette, Robert
    Ungar, Benjamin
    Suarez-Farinas, Mayte
    Ardeleanu, Marius
    Esaki, Hitokazu
    Suprun, Maria
    Estrada, Yeriel
    Xu, Hui
    Peng, Xiangyu
    Silverberg, Jonathan I.
    Menter, Alan
    Krueger, James G.
    Zhang, Rick
    Chaudhry, Usman
    Swanson, Brian
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Yancopoulos, George D.
    Hamilton, Jennifer D. D.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (01) : 155 - 172
  • [6] Efficacy and safety of mepolizumab administered subcutaneously for moderate to severe atopic dermatitis
    Kang, Eunhye G.
    Narayana, Poornima Krishnamurthy
    Pouliquen, Isabelle J.
    Lopez, Monica C.
    Ferreira-Cornwell, M. Celeste
    Getsy, John A.
    [J]. ALLERGY, 2020, 75 (04) : 950 - 953
  • [7] Matsunaga MC, 2016, J DRUGS DERMATOL, V15, P925
  • [8] Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor
    Molfino, N. A.
    Gossage, D.
    Kolbeck, R.
    Parker, J. M.
    Geba, G. P.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2012, 42 (05) : 712 - 737
  • [9] Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes
    Olaguibel, J. M.
    Sastre, J.
    Rodriguez, J. M.
    del Pozo, V
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2022, 32 (03) : 165 - 180
  • [10] Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases
    Pitlick, Mitchell M.
    Pongdee, Thanai
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2022, 15 (11):
12